Key information

🔎 Fund Overview

Rhinomed Ltd. is medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. The company is headquartered in Richmond, Victoria. The company went IPO on 2007-09-21. The firm is engaged in the research, development and commercialization of consumer and medical devices. The Company’s products include Mute, Turbine, Rhinoswab Junior, and Rhinoswab. Mute technology is an easily inserted, comfortable and fully adjustable nasal stent or dilator. Turbine is designed to fit comfortably inside the nose and gently open each individual nostril to allow more airflow during sport, physical exertion, or focused breathing, such as yoga and meditation. Rhinoswab is a patented comfortable, self-administered nasal swab that provides high-yield sampling and fits existing pathology workflows.